+971.7%
MRNA vs THC
+1,002.0%
-30.3%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | +1.3% | -2.9% | +4.1% | +1.6% |
| 7D | -13.8% | -8.1% | -5.7% | -13.1% |
| 30D | -17.7% | -3.2% | -14.5% | -17.4% |
| 3M | +14.3% | -1.8% | +16.1% | +14.5% |
| 6M | +336.0% | +37.7% | +298.3% | +321.6% |
| YTD | +575.9% | +32.6% | +543.3% | +553.7% |
| 1Y | +724.4% | +35.7% | +688.7% | +695.1% |
| 3Y | +160.8% | +313.5% | -152.8% | +126.5% |
| 5Y | -24.4% | +240.3% | -264.8% | -34.6% |
| All | +971.7% | +1,002.0% | -30.3% | +772.1% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling